chen
guo
jj
heali
dp
zhan
effect
integr
tradit
chines
medicin
western
medicin
treatment
sever
acut
respiratori
syndrom
metaanalysi
pharmaci
practic
wwwpharmacypracticeorg
abstract
background
data
regard
treatment
efficaci
integr
treatment
tradit
chines
medicin
tcm
western
medicin
wm
treat
patient
sar
conflict
effect
integr
tcmwm
treatment
fulli
quantifi
object
systemat
ass
treatment
effect
integr
tcm
wm
versu
wm
alon
patient
sar
incorpor
data
recent
publish
studi
method
metaanalysi
conduct
use
publish
random
nonrandom
control
clinic
studi
compar
treatment
effect
integr
tcmwm
wm
alon
outcom
measur
includ
mortal
rate
cure
rate
resolut
pulmonari
infiltr
use
corticosteroid
time
defervesc
effect
size
present
risk
ratio
rr
rate
differ
rd
weight
mean
differ
wmd
pool
effect
size
calcul
fixedeffect
randomeffect
model
result
total
patient
diagnosi
sar
identifi
includ
patient
random
control
studi
patient
nonrandom
control
studi
differ
detect
mortal
rate
cure
rate
treatment
compar
patient
receiv
wm
treatment
alon
patient
receiv
integr
treatment
like
complet
partial
resolut
pulmonari
infiltr
ci
lower
averag
daili
dosag
mg
corticosteroid
ci
higher
count
cellsul
ci
shorter
time
defervesc
day
wmd
ci
conclus
experi
integr
tcmwm
treatment
sar
encourag
use
tcm
adjunct
therapi
treatment
sar
investig
effect
integr
tradit
chines
medicin
western
medicin
treatment
sever
acut
respiratori
syndrom
metaanalysi
pharmaci
practic
wwwpharmacypracticeorg
dmp
ic
conclusion
la
experiencia
del
tratamiento
integrado
mtcto
para
el
sra
anima
el
uso
de
mtc
como
coadyuvant
en
tratamiento
de
sra
ser
investigado
palabra
clave
respiratorio
agudo
severo
medicina
tradicion
china
english
antecedent
lo
dato
sobr
la
eficacia
del
tratamiento
integrado
de
medicina
tradicion
china
mtc
de
tratamiento
occident
para
pacient
con
sra
son
controvertido
lo
efecto
del
tratamiento
mtcto
han
sido
completament
cuantificado
objetivo
evaluar
lo
efecto
del
tratamiento
integrado
de
mtc
con
contra
el
solo
en
pacient
con
srag
incorporando
dato
de
estudio
recientement
publicado
se
un
utilizando
lo
estudio
controlado
aleatorizado
aleatorizado
que
comparaban
la
eficacia
del
tratamiento
integrado
mtcto
con
el
solo
desd
la
medida
de
resultado
tasa
de
mortalidad
tasa
de
cura
de
infiltrado
pulmonar
uso
de
corticoid
tiempo
la
lo
efecto
fueron
presentado
como
riesgo
relativo
rr
tasa
de
diferencia
td
diferencia
media
ponderada
dmp
lo
efecto
combinado
se
calcularon
tanto
por
efecto
fijo
como
por
modelo
de
efecto
aleatorio
resultado
se
identificaron
un
total
de
pacient
con
de
sar
incluyendo
pacient
de
estudio
controlado
aleatorizado
pacient
de
estudio
controlado
aleatorizado
hubo
diferencia
detectada
en
la
tasad
e
mortalidad
tasa
de
cura
entr
lo
tratamiento
comparado
con
lo
pacient
recibiendo
solo
lo
pacient
que
recibieron
tratamiento
integrado
probabilidad
de
tener
una
total
parcial
del
infiltrado
pulmonar
consider
mind
conduct
metaanalysi
use
updat
literatur
search
ass
treatment
effect
integr
tcm
wm
patient
sar
determin
whether
integr
treatment
efficaci
wm
alon
reduc
mortal
rate
increas
cure
rate
improv
clinic
outcom
includ
studi
data
extract
review
yc
sz
complet
disagr
data
extract
studi
evalu
resolv
discuss
record
data
includ
studi
design
patient
characterist
medic
use
jadad
scale
use
assess
qualiti
includ
rc
studi
includ
method
random
doubl
blind
report
withdraw
dropout
one
point
given
ye
point
besid
individu
marker
includ
estim
sampl
size
intentiontotreat
itt
analysi
also
examin
includ
studi
measur
outcom
studi
includ
mortal
rate
cure
rate
resolut
lung
infiltr
dosag
corticosteroid
averag
daili
dosag
cumul
dosag
corticosteroid
cours
corticosteroid
treatment
count
time
defervesc
mortal
rate
defin
proport
death
among
patient
sar
receiv
treatment
cure
rate
defin
proport
patient
simultan
satisfi
three
follow
condit
patient
fever
remain
normal
least
seven
day
without
use
antifev
medic
symptom
respiratori
system
disappear
partial
complet
resolut
pulmonari
infiltr
demonstr
chest
radiograph
time
defervesc
defin
time
period
day
hospit
admiss
date
temperatur
patient
recov
normal
rang
stay
normal
least
seven
day
data
analyz
use
revman
cochran
collabor
oxford
uk
statist
signific
level
predetermin
level
effect
integr
treatment
present
risk
ratio
rr
rate
differ
rd
dichotom
outcom
weight
mean
differ
wmd
continu
outcom
rd
defin
differ
occurr
rate
event
integr
treatment
group
wm
alon
group
comput
rr
rd
wmd
given
follow
standard
formula
c
event
b
nonev
n
n
group
size
two
studi
group
studi
respect
pool
rr
rd
wmd
calcul
use
fixedeffect
randomeffect
model
test
heterogen
chi
squar
statist
signific
p
present
result
randomeffect
model
otherwis
estim
result
fixedeffect
model
present
order
exclud
bia
brought
nonrandom
control
clinic
studi
nrc
sensit
analysi
perform
reassess
treatment
effect
includ
random
control
clinic
studi
rc
addit
subset
analys
perform
robust
pool
estim
assess
repeat
metaanalysi
basi
sampl
size
presenc
adequ
inform
random
tabl
antisar
formula
evalu
ten
studi
herb
extract
evalu
three
studi
combin
herbal
medicin
evalu
eleven
studi
studi
three
studi
report
outcom
base
sever
diseas
rc
studi
provid
adequ
inform
method
blind
itt
accord
jadad
score
method
rc
studi
studi
score
point
remain
studi
score
point
ten
studi
report
mortal
rate
pool
mortal
rate
attribut
sar
integr
tcmwm
group
wm
alon
group
respect
base
sensit
analysi
nrc
studi
exclud
conclus
affect
ci
figur
howev
signific
differ
mortal
rate
treatment
detect
subset
analysi
ci
rc
studi
larger
sampl
size
adequ
inform
random
includ
tabl
ren
wang
zhang
zhang
yl
nine
studi
report
cure
rate
three
nrc
studi
posit
effect
improv
cure
rate
note
integr
treatment
regardless
inclus
nrc
studi
figur
howev
signific
differ
found
subset
analysi
ci
tabl
resolut
lung
infiltr
report
eight
studi
shown
figur
patient
receiv
integr
treatment
partial
complet
resolut
pulmonari
infiltr
significantli
higher
patient
wm
alon
group
ci
consist
find
note
sensit
subset
analys
ten
studi
report
use
corticosteroid
term
averag
daili
dosag
mg
averag
cumul
dosag
mg
treatment
cours
day
averag
daili
dosag
use
integr
tcmwm
treatment
group
significantli
lower
wm
alon
group
ci
signific
differ
two
group
either
averag
cumul
dosag
corticosteroid
ci
cours
corticosteroid
treatment
ci
four
studi
report
count
cellul
prior
treatment
signific
differ
count
two
group
ci
treatment
pool
wmd
two
group
ci
indic
signific
differ
recoveri
count
integr
treatment
group
wm
alon
group
eight
studi
report
time
day
fever
resolut
pool
wmd
integr
tcmwm
treatment
group
wm
alon
group
ci
figur
suggest
integr
treatment
could
significantli
reduc
time
defervesc
patient
sar
consist
find
found
sensit
subset
analys
base
sensit
analysi
result
affect
exclus
nrc
studi
figur
addit
subset
analys
found
previous
observ
differ
mortal
rate
cure
rate
becam
insignific
rc
studi
larger
sampl
size
adequ
random
inform
includ
tabl
present
studi
summar
result
find
rc
studi
npc
studi
use
metaanalysi
convinc
evid
support
integr
tcmwm
treatment
could
significantli
decreas
mortal
rate
contrast
find
liu
et
al
studi
although
first
note
signific
reduct
mortal
rate
integr
treatment
ten
studi
includ
subgroup
analys
fail
consist
find
signific
differ
mortal
rate
rc
studi
larger
sampl
size
adequ
inform
random
suggest
previous
observ
posit
effect
integr
treatment
like
due
inclus
studi
poor
qualiti
studi
overal
subgroup
analys
provid
clear
evid
support
notion
integr
tcmwm
treatment
might
effect
clear
lung
infiltr
shorten
time
defervesc
wm
treatment
alon
find
consist
result
previous
publish
metaanalysi
studi
found
larg
percent
patient
sar
present
lymphopenia
low
count
often
associ
advers
outcom
recov
lymphocyt
cell
becam
critic
treatment
issu
present
studi
patient
receiv
integr
tcmwm
treatment
significantli
higher
count
ul
end
studi
ci
limit
followup
well
effect
could
translat
clinic
outcom
unknown
aspect
benefit
certainli
warrant
investig
studi
suggest
adjunct
use
tcm
wm
could
significantli
reduc
averag
daili
use
corticosteroid
date
use
corticosteroid
patient
sar
remain
controversi
one
import
concern
occurr
advers
event
associ
use
corticosteroid
develop
aspergillu
fungal
infect
recent
literatur
report
chines
sar
survivor
receiv
highdos
corticosteroid
treatment
suffer
femor
head
necrosi
follow
therapi
identifi
studi
use
analysi
longterm
outcom
report
question
clinic
relev
observ
benefit
integr
treatment
reduc
averag
daili
dose
corticosteroid
whether
could
lead
lower
risk
develop
corticosteroidsrel
advers
event
answer
yet
studi
find
studi
consid
within
context
limit
first
due
limit
number
publish
rct
studi
analysi
also
includ
nrc
studi
howev
sudden
outbreak
new
seriou
diseas
preclud
well
control
clinic
studi
epidem
despit
twentyfour
clinic
studi
low
methodolog
qualiti
accord
jadad
score
second
variat
treatment
regimen
particularli
wide
rang
tcm
concoct
constitu
dose
rout
administr
durat
therapi
becam
major
obstacl
clear
interpret
result
third
three
studi
report
outcom
basi
sever
diseas
data
insuffici
conduct
effect
subset
analysi
sever
diseas
fourth
diagnos
sar
outbreak
confirm
laboratori
evid
sarscov
infect
recent
studi
indic
patient
eventu
confirm
sar
accord
tpct
detect
sarscov
rna
fifth
varieti
tcm
wm
studi
would
difficult
meaning
measur
rate
advers
event
relat
treatment
therefor
analysi
advers
event
conduct
part
present
studi
experi
integr
tcmwm
treatment
sar
encourag
studi
demonstr
possibl
integr
tcmwm
treatment
might
benefici
modal
treatment
sar
especi
quicken
resolut
lung
infiltr
increas
count
reduc
time
defervesc
clearli
studi
need
futur
outbreak
sar
qualiti
studi
evalu
tcm
need
improv
studi
aim
standard
tcm
treatment
includ
longterm
followup
major
outcom
order
strengthen
rational
use
tcm
